6-30986478-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_001010909.5(MUC21):c.303G>A(p.Gly101Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0018 in 1,599,330 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0020 ( 4 hom., cov: 34)
Exomes 𝑓: 0.0018 ( 22 hom. )
Consequence
MUC21
NM_001010909.5 synonymous
NM_001010909.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.20
Genes affected
MUC21 (HGNC:21661): (mucin 21, cell surface associated) This gene encodes a large membrane-bound glycoprotein which is a member of the mucin family. Mucins are O-glycosylated proteins that play an essential role in forming protective mucous barriers on epithelial surfaces. These proteins also play a role in intracellular signaling. The encoded protein contains an N-terminal signal sequence, an extracellular mucin domain, a stem domain, a transmembrane domain, and a C-terminal cytoplasmic tail domain. The mucin domain contains O-glycosylation sites and is polymorphic with isoforms containing a variable number of nonidentical proline-, threonine-, and serine-rich tandem repeats of 15 amino acids each. The aberrent expression of this gene is associated with lung adenocarcinoma. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 6-30986478-G-A is Benign according to our data. Variant chr6-30986478-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2656348.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.2 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00178 (2581/1447616) while in subpopulation MID AF= 0.0287 (163/5678). AF 95% confidence interval is 0.0251. There are 22 homozygotes in gnomad4_exome. There are 1349 alleles in male gnomad4_exome subpopulation. Median coverage is 166. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MUC21 | NM_001010909.5 | c.303G>A | p.Gly101Gly | synonymous_variant | 2/3 | ENST00000376296.3 | NP_001010909.2 | |
MUC21 | NR_130720.3 | n.686G>A | non_coding_transcript_exon_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MUC21 | ENST00000376296.3 | c.303G>A | p.Gly101Gly | synonymous_variant | 2/3 | 1 | NM_001010909.5 | ENSP00000365473.3 | ||
MUC21 | ENST00000486149.2 | c.-1060G>A | 5_prime_UTR_variant | 2/3 | 1 | ENSP00000457640.1 |
Frequencies
GnomAD3 genomes AF: 0.00202 AC: 306AN: 151598Hom.: 4 Cov.: 34
GnomAD3 genomes
AF:
AC:
306
AN:
151598
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00291 AC: 732AN: 251310Hom.: 4 AF XY: 0.00312 AC XY: 424AN XY: 135832
GnomAD3 exomes
AF:
AC:
732
AN:
251310
Hom.:
AF XY:
AC XY:
424
AN XY:
135832
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00178 AC: 2581AN: 1447616Hom.: 22 Cov.: 166 AF XY: 0.00187 AC XY: 1349AN XY: 720434
GnomAD4 exome
AF:
AC:
2581
AN:
1447616
Hom.:
Cov.:
166
AF XY:
AC XY:
1349
AN XY:
720434
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00200 AC: 304AN: 151714Hom.: 4 Cov.: 34 AF XY: 0.00212 AC XY: 157AN XY: 74158
GnomAD4 genome
AF:
AC:
304
AN:
151714
Hom.:
Cov.:
34
AF XY:
AC XY:
157
AN XY:
74158
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | MUC21: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at